drugset / Trial / NCT02503189
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Summary
The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome
Timeline
- Start
- —
- Primary completion
- 2017-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ozagrel | Small molecule | — | — |